Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hyperphosphatasaemia
ADR Hierarchy
09      Hepatobiliary disorders
09.01      Hepatic and hepatobiliary disorders
09.01.08      Hepatic and hepatobiliary disorders NEC      Hyperphosphatasaemia
14      Metabolism and nutrition disorders
14.11      Metabolism disorders NEC
14.11.01      Metabolic disorders NEC      Hyperphosphatasaemia
15      Musculoskeletal and connective tissue disorders
15.02      Bone disorders (excl congenital and fractures)
15.02.04      Bone disorders NEC      Hyperphosphatasaemia
Description Not Available
MedDRA Code 10060851
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Hyperphosphatasaemia | Hyperphosphatasemia
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Alanine aminotransferase 1P24298Not Available
Alpha-2A adrenergic receptorP08913T11448
Bile salt export pumpO95342T33969
C-C chemokine receptor type 4P51679T06955
C-C chemokine receptor type 9P51686T97873
C-C motif chemokine 2P10148Not Available
C-X-C chemokine receptor type 3P49682T25315
Cytochrome P450Q80XK1Not Available
Intercellular adhesion molecule 1P05362T26203
Interleukin-10P18893Not Available
Interleukin-6P08505Not Available
Methylenetetrahydrofolate reductaseQ9WU20Not Available
Tumor necrosis factorP06804Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00044Adefovir dipivoxil0.003617%
The 1th Page    1    Total 1 Pages